Autopsy report · NCT05201027

Study to Optimize the IOL Constant of a New Multifocal Intraocular Lens

“Sponsor decided to modify the prototype device used in study”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 months before it stopped.
• 52 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Carl Zeiss Meditec AG

Sponsor type

Industry

Conditions

Cataract Senile

Interventions

trifocal intraocular lens

Participants

52

Sites

1

Countries

El Salvador

Trials that died the same way

• Gynecare TVT Secur for the Management of Stress Urinary Incontinence (SUI)
  “Study design required a change in device” (76% match in meaning)
• Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
  “The sponsor decided to change the investigational product for a strategic reason.” (64% match in meaning)
• Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure
  “Sponsor no longer pursuing regulatory approval of investigational device” (64% match in meaning)
• Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion
  “Sponsor preferred a better study design” (63% match in meaning)
• Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
  “Sponsor has designed another study with different endpoint to replace the current study” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.